spacer
home > ict > summer 2007 > clinical teams and tools
PUBLICATIONS
International Clinical Trials

Clinical Teams and Tools

New approaches for smarter clinical trials come under review, as Hui Li and Eva R Miller of ALMAC Clinical Technologies go in search of a strategic plan

Doing things the same way and expecting different results. Most of us are familiar with this definition of insanity. Thus, improving the clinical trial process requires that we find new ways to work more efficiently and effectively. In short, we need to work smarter. Improved collaboration and the better utilisation of technology are areas that hold promise for improving the clinical trial process. In both cases, doing things the same way we always have won’t result in the outcomes we are hoping for. Instead, we need to break the mould and find new ways to leverage the tools and talents that are available.

THE POWER OF EDC

Electronic data capture (EDC) systems are cost effective when they help sponsors process their data more efficiently, in effect by ‘keeping the end in sight’. If teams anticipate study reports and filing as they develop an EDC system, only information that is really necessary is collected and cleaned. In addition to the efficiency this brings to the data collection process, it also eliminates the risk of getting to the end of the study and realising that essential information is missing. Modern EDC technologies have the potential to help clinical research teams collect data in a much more precise, rapid and accurate way, which in turn results in high quality data, ready for analysis more quickly.

The implementation of EDC has caused changes in the roles of various members of the clinical team. The teamwork of statisticians, data manager and other team members in the establishment of EDC trials is essential. Wise planning in the use of EDC technology allows for cleaner data to be entered into the clinical trial; it is more accurate, comprehensive and timely.

CHANGING ROLE OF DATA MANAGERS

Traditionally in clinical trials, data has been collected on paperbased case report forms (CRFs). After the CRFs are completed, batched and transmitted, the data managers perform edit checks to make sure there are no obvious mistakes, and all the required fields have been completed. The CRFs are then entered into the database manually or scanned by a text-recognition device such as an OCR. Again, the data in the database needs to be compared against the original documents in order to make sure that no errors have been introduced during the digitalisation process (1).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Hui Li, Biostatistician at ALMAC Clinical Technologies, gained a Master’s from Rutgers, the State University of New Jersey. Hui has served as a Biostatistician, providing randomisation lists generation and statistical consulting services for a broad range of clients. She is also involved in the development of electronic data capture and electronic patient report outcomes.

Eva R Miller, Head of Biostatistics at ALMAC Clinical Technologies, holds a PhD from the University of Pennsylvania. At ALMAC, she oversees development of EDC and randomisation modules for clinical trials. Eva has served as a Biostatistician in clinical trials spanning Phase I through Phase IV in a broad range of therapeutic areas. Eva’s most recent research has focused on innovative designs for clinical trials, logistics for implementing adaptive trials and adaptive randomisation designs.

spacer
Hui Li
spacer
spacer
spacer
Eva R Miller
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement